Mobile shielding evaluation on the fetal dose during a breast radiotherapy using Monte Carlo simulation |
| |
| Institution: | 1. Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil;2. Federal University of Uberlândia (INFIS/UFU), Uberlândia, MG, Brazil;3. Cancer Institute of Ceará, Fortaleza, CE, Brazil;1. Universidade Federal de Sergipe, Departamento de Física, Av. Marechal Rondon, s/n – Jd. Rosa Elze, 50740-540 São Cristóvão, SE, Brazil;2. Universidade Federal de Uberlândia, Instituto de Física, Laboratório de Novos Materiais Isolantes e Semicondutores (LNMIS), Uberlândia, MG, Brazil;3. Instituto de Pesquisas Energéticas e Nucleares, Comissão Nacional de Energia Nuclear, IPEN-CNEN, São Paulo, Brazil;4. Università di Pisa, Scuola di Ingegneria, Largo L. Lazzarino 2, Pisa I-56122, Italy;5. Yale University, School of Medicine, PO Box 208042, New Haven, CT 06520-8042, United States;1. Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-Ku, Nagoya, Aichi 464-8681, Japan;2. Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, 323-1 Kamioki, Maebashi, Gunma 371-0052, Japan;3. Graduate School of Medicine, Aichi Medical University, 1-1 Yazako-karimata, Nagakute, Aichi 480 1195, Japan;1. Department of Medical Physics, Graduate School of Medical Sciences, Kindai University, Osaka-Sayama, Osaka 589-8511, Japan;2. Department of Central Radiology, Kindai University Hospital, Osaka-Sayama, Osaka 589-8511, Japan;3. Department of Biomedical Engineering and Research Institute of Biomedical Engineering, College of Medicine, Catholic University of Korea, Seoul 06591, South Korea;4. Department of Radiation Oncology, Faculty of Medicine, Kindai University, 377-2 Ohno-higashi, Osaka-Sayama, Osaka 589-8511, Japan;5. Department of Oral Radiology, Osaka Dental University, 1-5-17 Otemae Chuo-ku, Osaka 540-0008, Japan;1. Cancer Care Services, Royal Brisbane and Women’s Hospital, Herston, Qld, Australia;2. Herston Biofabrication Institute, Metro North Hospital and Health Service, Herston, Qld, Australia;3. School of Information Technology and Electrical Engineering, University of Queensland, St. Lucia, Qld, Australia;4. School of Chemistry and Physics, Queensland University of Technology, Brisbane Qld, Australia;5. Nuclear Medicine, Royal Brisbane and Women’s Hospital, Herston, Qld, Australia |
| |
| Abstract: | PurposeEvaluation of the out-of-field dose is an important aspect in radiotherapy. Due to the fetus radiosensitivity, this evaluation becomes even more conclusive when the patient is pregnant. In this work, a linear accelerator Varian Clinac 2100c operating at 6 MV, a pregnant anthropomorphic phantom (Maria), and different shields added above the abdominal region of the phantom were used for the analysis based on MCNPX. Methods: The simulations were performed for the medial and lateral projections, using either an open field collimation (10×16 cm2) or a multileaf collimator. The added shields (M1 and M2) were designed based on models proposed by Stovall et al. 1], intending to reduce the deposited dose on the fetus and related structures. Results: The presence of the shields showed to be effective in reducing the doses on the fetus, amniotic sac, and placenta, for example. A reduction of about 43% was found in the dose on the fetus when M2 was added, using the open field collimation, in comparison with the situation with no shield, being the lateral projection the main responsible for the dose. The use of MLC significatively reduced the doses in different structures, including on the fetus and amniotic sac, for example, in comparison to the open field situation. A slight increment on the dose in organs such as the eyes, thyroid and brain was found in both collimation systems, due to the presence of the shields. The contribution of the leakage radiation from the tube head of the linear accelerator was found to be in the order of µGy, being reduced by the presence of the M2 shield. Conclusion: Using the shields showed to be an essential feature in order to reduce the dose not only on the fetus, but also in important structures responsible to its development. |
| |
| Keywords: | Monte Carlo simulation Anthropomorphic phantom Fetal dose Breast radiotherapy Mobile shielding |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
